Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma: Preliminary Toxicity and Activity Data in Dogs

Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma: Preliminary Toxicity and Activity Data in Dogs

Unresectable nodular and diffuse hepatocellular carcinoma (HCC) have a poor prognosis with limited treatment options. Systemic traditional chemotherapy has been only rarely reported, with unsatisfactory results. The aim of this prospective, non-randomized, non-blinded, single center clinical trial w...

Full description

Bibliographic Details
Main Authors: Laura Marconato, Silvia Sabattini, Giorgia Marisi, Federica Rossi, Vito Ferdinando Leone, Andrea Casadei-Gardini
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Cancers
Subjects:
dog
hepatocellular carcinoma
metronomic therapy
outcome
sorafenib
toxicity
Online Access:https://www.mdpi.com/2072-6694/12/5/1272

Internet

https://www.mdpi.com/2072-6694/12/5/1272

Similar Items